Abstract
The central nervous system (CNS) is composed of numerous neural cells such as neurons and glias that have wide cell surface and numerous processes covered with plasma membranes. As the plasma membrane is enriched in cholesterol, the CNS composed of numerous neural cells with wide plasma membrane is a cholesterol- rich organ. Because inhibition of cholesterol supply induces cell death into neurons, the CNS is also an organ to highly require cholesterol. It is known that intercellular cholesterol transport is mainly maintained by generation of apolipoprotein- mediated high-density lipoproteins (HDL) in astrocytes and its supply to neuronal cells. Therefore, a study to elucidate a mechanism underlying the generation of HDL in astrocytes is one of important research subjects to understand cholesterol homeostasis in the brain.
In this context, it is of note that we have found cytosolic lipid-protein particles (CLPPs) to mediate intracellular cholesterol transport leading to HDL generation in rat astrocytes. The CLPPs are lipoprotein- like complexes composed of proteins such as caveolin-1 and cyclophilin A and lipids such as cholesterol, sphingomyelin, and phosphatidylcholine in the cytosol. It was shown by using specific enzyme inhibitors that exogenous apolipoprotein A-I (apoA-I) interacts with the membraneassociated ATP-binding cassette transporter A1 (ABCA1) to promote the CLPP-mediated intracellular transport of newly synthesized cholesterol through activation of ABCA1-binding phospholipase Cγ and protein kinase Cα. An inhibitor of phosphatidylcholine-specific phospholipase C, D609, reduces sphingomyelin synthesis and apoA-I-mediated HDL generation. These findings suggest that sphingomyelin synthesis is important for intracellular cholesterol transport to the plasma membrane and cholesterol efflux to generate apoA-I-containing HDL (apoA-I/HDL). A cyclophilin A inhibitor, cyclosporin A (Cs-A), suppresses not only exogenous apoA-I-mediated cholesterol efflux but also intracellular cholesterol transport through the inhibition of assembly of caveolin-1 and cholesterol to the CLPPs. Based on these findings, it is suggested that the CLPPs contribute to the intracellular cholesterol transport and cholesterol efflux to generate apoA-I/HDL. The mechanism underlying intracellular cholesterol transport, by which HDL generation and cholesterol homeostasis are regulated in the brain, is discussed focusing on our findings in this review.
Keywords: Astrocytes, apoA-I, HDL, sphingomyelinase, sphingomyelin synthesis, D609.
Graphical Abstract
Current Enzyme Inhibition
Title:Utilization of Enzyme Inhibitors in Study of Mechanism Underlying apoA-I-mediated HDL Generation in Rat Brain Astrocytes
Volume: 11 Issue: 1
Author(s): Jinichi Ito and Makoto Michikawa
Affiliation:
Keywords: Astrocytes, apoA-I, HDL, sphingomyelinase, sphingomyelin synthesis, D609.
Abstract: The central nervous system (CNS) is composed of numerous neural cells such as neurons and glias that have wide cell surface and numerous processes covered with plasma membranes. As the plasma membrane is enriched in cholesterol, the CNS composed of numerous neural cells with wide plasma membrane is a cholesterol- rich organ. Because inhibition of cholesterol supply induces cell death into neurons, the CNS is also an organ to highly require cholesterol. It is known that intercellular cholesterol transport is mainly maintained by generation of apolipoprotein- mediated high-density lipoproteins (HDL) in astrocytes and its supply to neuronal cells. Therefore, a study to elucidate a mechanism underlying the generation of HDL in astrocytes is one of important research subjects to understand cholesterol homeostasis in the brain.
In this context, it is of note that we have found cytosolic lipid-protein particles (CLPPs) to mediate intracellular cholesterol transport leading to HDL generation in rat astrocytes. The CLPPs are lipoprotein- like complexes composed of proteins such as caveolin-1 and cyclophilin A and lipids such as cholesterol, sphingomyelin, and phosphatidylcholine in the cytosol. It was shown by using specific enzyme inhibitors that exogenous apolipoprotein A-I (apoA-I) interacts with the membraneassociated ATP-binding cassette transporter A1 (ABCA1) to promote the CLPP-mediated intracellular transport of newly synthesized cholesterol through activation of ABCA1-binding phospholipase Cγ and protein kinase Cα. An inhibitor of phosphatidylcholine-specific phospholipase C, D609, reduces sphingomyelin synthesis and apoA-I-mediated HDL generation. These findings suggest that sphingomyelin synthesis is important for intracellular cholesterol transport to the plasma membrane and cholesterol efflux to generate apoA-I-containing HDL (apoA-I/HDL). A cyclophilin A inhibitor, cyclosporin A (Cs-A), suppresses not only exogenous apoA-I-mediated cholesterol efflux but also intracellular cholesterol transport through the inhibition of assembly of caveolin-1 and cholesterol to the CLPPs. Based on these findings, it is suggested that the CLPPs contribute to the intracellular cholesterol transport and cholesterol efflux to generate apoA-I/HDL. The mechanism underlying intracellular cholesterol transport, by which HDL generation and cholesterol homeostasis are regulated in the brain, is discussed focusing on our findings in this review.
Export Options
About this article
Cite this article as:
Ito Jinichi and Michikawa Makoto, Utilization of Enzyme Inhibitors in Study of Mechanism Underlying apoA-I-mediated HDL Generation in Rat Brain Astrocytes, Current Enzyme Inhibition 2015; 11 (1) . https://dx.doi.org/10.2174/1573408011666150302220800
DOI https://dx.doi.org/10.2174/1573408011666150302220800 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Implication of Prophetic Variables and their Impulsive Interplay in CA Prostate Patients Experiencing Osteo-Metastasis
Anti-Cancer Agents in Medicinal Chemistry Anti-Insulin Receptor Antibodies in the Pathology and Therapy of Diabetes Mellitus
Current Diabetes Reviews Iontophoretic Mediated Intraarticular Delivery of Deformable Liposomes of Diclofenac Sodium
Current Drug Delivery The Role of Imaging in Computer-Assisted Tumor Surgery of the Sacrum and Pelvis
Current Medical Imaging Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma
Current Cancer Drug Targets Antiproliferative and Antifungal Activities of 1,3-diarylpropane-1,3-diones Commonly used as Sunscreen Agents
Letters in Drug Design & Discovery Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine Updates of mTOR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Sanguinarine: A Double-Edged Sword of Anticancer and Carcinogenesis and Its Future Application Prospect
Anti-Cancer Agents in Medicinal Chemistry Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets Emerging Anabolic Treatments in Osteoporosis
Current Drug Safety Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity
Anti-Cancer Agents in Medicinal Chemistry Subject Index Volume 2
Current Pediatric Reviews Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level
Current Genomics MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Current Drug Targets Molecular Mechanisms of Pancreatic Cancer Dissemination: The Role of the Chemokine System
Current Pharmaceutical Design The Effects of Statin Therapy on the Human Airway
Drug Metabolism Letters Insulin Analogs Revisited
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents